Myocardial damages in systemic sclerosis detected by gated myocardial perfusion SPECT and sympathetic imaging

Circulation Journal

Volumn 70, Issue 11, 2006, Pages 1481-1487

  Nakajima, Kenichi ^a   Kawano, Masaya ^a   Hasegawa, Minora ^a   Taki, Junichi ^a   Fujimoto, Manabu ^a   Takehara, Kazuhiko ^a   Tonami, Norihisa ^a  

^a KANAZAWA UNIVERSITY HOSPITAL   (Japan)

Author keywords

123I metaiodobenzylguanidine; Diastolic function; Gated SPECT; Sympathetic imaging; Systemic sclerosis

Indexed keywords

METAIODOBENZYLGUANIDINE IODINE 123; METHOXY ISOBUTYL ISONITRILE TECHNETIUM TC 99M; RADIOPHARMACEUTICAL AGENT; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; GATED IMAGING; HEART LEFT VENTRICLE EJECTION FRACTION; HEART MUSCLE INJURY; HEART MUSCLE PERFUSION; HUMAN; ISCHEMIA; MALE; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; SKINFOLD THICKNESS; SYSTEMIC SCLEROSIS;

3-IODOBENZYLGUANIDINE; ADULT; AGED; DIASTOLE; FEMALE; HEART; HEART DISEASES; HUMANS; MALE; MIDDLE AGED; MYOCARDIUM; RADIOPHARMACEUTICALS; SCLERODERMA, SYSTEMIC; SEVERITY OF ILLNESS INDEX; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON; VENTRICULAR DYSFUNCTION, LEFT;

EID: 33750557017     PISSN: 13469843     EISSN: 13474820     Source Type: Journal    
DOI: 10.1253/circj.70.1481     Document Type: Article

References (27)

1. Generini S, Fiori G, Moggi Pignone A, Matucci Cerinic M, Cagnoni M. Systemic sclerosis: A clinical overview. Adv Exp Med Bio. 1999; 455: 73-83.
2. D'angelo W, Fries J, Masi A, Shulman L. Pathologic observation in systemic sclerosis (scleroderma): A study of fifty-eight autopsy cases and fifty-eight matched controls. Am J Med 1969; 46: 428-440.
3. Ridolfi R, Bulkley B, Hutchins G. The cardiac conduction system in progressive systemic sclerosis: Clinical and pathologic features of 35 patients. Am J Med 1976; 61: 361-366.
4. Follansbee WP, Curtiss EI, Medsger TA Jr, Steen VD, Uretsky BF, Owens GR, et al. Physiologic abnormalities of cardiac function in progressive systemic sclerosis with diffuse scleroderma. N Engl J Med 1984; 310: 142-148.
5. Alexander EL, Firestein GS, Weiss JL, Heuser RR, Leitl G, Wagner HN Jr, et al. Reversible cold-induced abnormalities in myocardial perfusion and function in systemic sclerosis. Ann Intern Med 1986; 105: 661-668.
6. Hsu HB, Kao CH. Usefulness of technetium-99m tetrofosmin SPECT to detect abnormal myocardial perfusion in systemic lupus erythematosus or systemic sclerosis patients. Clin Rheumatol 2003; 22: 495.
7. Nakajima K, Taki J, Kawano M, Higuchi T, Sato S, Nishijima C, et al. Diastolic dysfunction in patients with systemic sclerosis detected by gated myocardial perfusion SPECT: An early sign of cardiac involvement. J Nucl Med 2001; 42: 183-188.
8. Gurtner C, Werner RJ, Winten G, Krause BJ, Wendt T, Hor G, et al. Early diagnosis of cardiac involvement in systemic sclerosis by 123I-MIBG neurotransmitter scintigraphy. Nucl Med Commun 1998; 19: 849-857.
9. Subcommittee for scleroderma criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee. Preliminary criteria for the classification of systemic sclerosis (scleroderma). Arthritis Rheum 1980; 23: 581-590.
10. LeRoy EC, Black C, Fleischmajer R, Jablonska S, Krieg T, Medsger TA Jr, et al. Scleroderma (systemic sclerosis): Classification, subsets and pathogenesis. J Rheumatol 1988; 15: 202-205.
11. Clements PJ, Lachenbruch PA, Seibold JR, Zee B, Steen VD, Brennan P, et al. Skin thickness score in systemic sclerosis: An assessment of interobserver variability in 3 independent studies. J Rheumatol 1993; 20: 1892-1896.
12. Furst DE, Clements PJ, Steen VD, Medsger TA Jr, Masi AT, D'Angelo WA, et al. The modified Rodnan skin score is an accurate reflection of skin biopsy thickness in systemic sclerosis. J Rheumatol 1998; 25: 84-88.
13. Takehara K, Sato S (editors). The clarification of pathogenesis and the development of therapy in systemic sclerosis: The classification of severity and the guideline for treatment: A research project for systemic sclerosis supported by Japanese Ministry of Health and Welfare. Tokyo: The Ministry; 2004.
14. Grundy SM, Pasternak R, Greenland P, Smith S Jr, Fuster V. Assessment of cardiovascular risk by use of multiple-risk-factor assessment equations: A statement for healthcare professionals from the American Heart Association and the American College of Cardiology. Circulation 1999; 100: 1481-1492.
15. Gustafsson R, Mannting F, Kazzam E, Waldenstrom A, Hallgren R. Cold-induced reversible myocardial ischaemia in systemic sclerosis. Lancet 1989; 2: 475-479.
16. Ishida R, Murata Y, Sawada Y, Nishioka K, Shibuya H. Thallium-201 myocardial SPECT in patients with collagen disease. Nucl Med Commun 2000; 21: 729-734.
17. Lin CC, Ding HJ, Chen YW, Wang JJ, Ho ST, Kao A. Usefulness of technetium-99m sestamibi myocardial perfusion SPECT in detection of cardiovascular involvement in patients with systemic lupus erythematosus or systemic sclerosis. Int J Cardiol 2003; 92: 157-161.
18. Clements P, Lachenbruch P, Siebold J, White B, Weiner S, Martin R, et al. Inter and intraobserver variability of total skin thickness score (modified Rodnan TSS) in systemic sclerosis. J Rheumatol 1995; 22: 1281-1285.
19. Medsger TA Jr, Silman AJ, Steen VD, Black CM, Akesson A, Bacon PA, et al. A disease severity scale for systemic sclerosis: Development and testing. J Rheumatol 1999; 26: 2159-2167.
20. Murata I, Takenaka K, Shinohara S, Suzuki T, Sasaki T, Yamamoto K. Diversity of myocardial involvement in systemic sclerosis: An 8-year study of 95 Japanese patients. Am Heart J 1998; 135: 960-969.
21. Higuchi T, Nakajima K, Taki J, Kinuya S, Bunko H, Tonami N. Assessment of left ventricular systolic and diastolic function based on the edge detection method with myocardial ECG-gated SPET. Eur J Nucl Med 2001; 28: 1512-1516.
22. 99mTc-tetrofosmin myocardial SPET. Eur J Nucl Med 2001; 28: 593-601.
23. 99mTc-sestamibi gated myocardial perfusion SPECT: Normal values. J Nucl Med 2005; 46: 1102-1108.
24. Valentini G, Vitale DF, Giunta A, Maione S, Gerundo G, Arnese M, et al. Diastolic abnormalities in systemic sclerosis: Evidence for associated defective cardiac functional reserve. Ann Rheum Dis 1996; 55: 455-460.
25. Dessein PH, Joffe BI, Metz RM, Millar DL, Lawson M, Stanwix AE. Autonomic dysfunction in systemic sclerosis: Sympathetic overactivity and instability. Am J Med 1992; 93: 143-150.
26. Klimiuk PS, Taylor L, Baker RD, Jayson MI. Autonomic neuropathy in systemic sclerosis. Ann Rheum Dis 1988; 47: 542-545.
27. Pancera P, Sansone S, Presciuttini B, Montagna L, Ceru S, Lunardi C, et al. Autonomic nervous system dysfunction in sclerodermic and primary Raynaud's phenomenon. Clin Sci (Lond) 1999; 96: 49-57.